Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 1
2020 2
2021 2
2022 1
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year

Filters applied: . Clear all
Page 1
Influenza vaccine: progress in a vaccine that elicits a broad immune response.
Isakova-Sivak I, Stepanova E, Mezhenskaya D, Matyushenko V, Prokopenko P, Sychev I, Wong PF, Rudenko L. Isakova-Sivak I, et al. Among authors: prokopenko p. Expert Rev Vaccines. 2021 Sep;20(9):1097-1112. doi: 10.1080/14760584.2021.1964961. Epub 2021 Aug 17. Expert Rev Vaccines. 2021. PMID: 34348561
Development of a T Cell-Based COVID-19 Vaccine Using a Live Attenuated Influenza Vaccine Viral Vector.
Isakova-Sivak I, Stepanova E, Matyushenko V, Niskanen S, Mezhenskaya D, Bazhenova E, Krutikova E, Kotomina T, Prokopenko P, Neterebskii B, Doronin A, Vinogradova E, Yakovlev K, Sivak K, Rudenko L. Isakova-Sivak I, et al. Among authors: prokopenko p. Vaccines (Basel). 2022 Jul 18;10(7):1142. doi: 10.3390/vaccines10071142. Vaccines (Basel). 2022. PMID: 35891306 Free PMC article.
Expression of the SARS-CoV-2 receptor-binding domain by live attenuated influenza vaccine virus as a strategy for designing a bivalent vaccine against COVID-19 and influenza.
Stepanova E, Isakova-Sivak I, Mezhenskaya D, Niskanen S, Matyushenko V, Bazhenova E, Rak A, Wong PF, Prokopenko P, Kotomina T, Krutikova E, Legotskiy S, Neterebskii B, Ostroukhova T, Sivak K, Orshanskaya Y, Yakovlev K, Rudenko L. Stepanova E, et al. Among authors: prokopenko p. Virol J. 2024 Apr 9;21(1):82. doi: 10.1186/s12985-024-02350-w. Virol J. 2024. PMID: 38589848 Free PMC article.
Conserved T-cell epitopes of respiratory syncytial virus (RSV) delivered by recombinant live attenuated influenza vaccine viruses efficiently induce RSV-specific lung-localized memory T cells and augment influenza-specific resident memory T-cell responses.
Matyushenko V, Kotomina T, Kudryavtsev I, Mezhenskaya D, Prokopenko P, Matushkina A, Sivak K, Muzhikyan A, Rudenko L, Isakova-Sivak I. Matyushenko V, et al. Among authors: prokopenko p. Antiviral Res. 2020 Oct;182:104864. doi: 10.1016/j.antiviral.2020.104864. Epub 2020 Jun 22. Antiviral Res. 2020. PMID: 32585323 Free PMC article.
Recombinant Live Attenuated Influenza Vaccine Viruses Carrying Conserved T-cell Epitopes of Human Adenoviruses Induce Functional Cytotoxic T-Cell Responses and Protect Mice against Both Infections.
Isakova-Sivak I, Matyushenko V, Stepanova E, Matushkina A, Kotomina T, Mezhenskaya D, Prokopenko P, Kudryavtsev I, Kopeykin P, Sivak K, Rudenko L. Isakova-Sivak I, et al. Among authors: prokopenko p. Vaccines (Basel). 2020 Apr 24;8(2):196. doi: 10.3390/vaccines8020196. Vaccines (Basel). 2020. PMID: 32344618 Free PMC article.
Live attenuated influenza vaccine viral vector induces functional cytotoxic T-cell immune response against foreign CD8+ T-cell epitopes inserted into NA and NS1 genes using the 2A self-cleavage site.
Kotomina T, Korenkov D, Matyushenko V, Prokopenko P, Rudenko L, Isakova-Sivak I. Kotomina T, et al. Among authors: prokopenko p. Hum Vaccin Immunother. 2018;14(12):2964-2970. doi: 10.1080/21645515.2018.1502529. Epub 2018 Aug 29. Hum Vaccin Immunother. 2018. PMID: 30024831 Free PMC article.